The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip

Journal of Rheumatology

Volumn 24, Issue 8, 1997, Pages 1486-1488

  Wolfe, Frederick ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

Author keywords

C reactive protein; disease activity; erythrocyte sedimentation rate; osteoarthritis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COXITIS; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; KNEE OSTEOPOROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KNEE JOINT; MALE; OSTEOARTHRITIS; OSTEOARTHRITIS, HIP; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 0030808920     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Loose LD, de Oliveira R, Sipe JD, Franzblau C, Shanahan WR: A possible systemic component of osteoarthritis: Elevated concentrations (by ELISA) of C-reactive protein in the serum of OA patients and modulation by tenidap (abstr). Arthritis Rheum 1996;(suppl)36:S166.
2. Altman RD, Alarcón GS, Appelrouth D, et al: The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505-14.
3. Anonymous: Etodolac vs Diclofenac Protocol 654A-328-US. 1992.
4. Altman RD: Criteria for the classification of osteoarthritis of the knee and hip. Scand J Rheumatol 1987;(suppl)65:31-9.
5. Wolfe F, Michaud K: The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol 1994;21:1227-37.
6. Wolfe F: Data collection and utilization: A methodology for clinical practice and clinical research. In: Wolfe F, Pincus T, eds. Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. New York: Marcel Dekker, 1994:463-514.
7. Fries JF, Spitz PW, Kraines RG: Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
8. Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF: The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 1988;15:1480-8.
9. Hawley DJ, Wolfe F: Depression is not more common in rheumatoid arthritis: A 10 year longitudinal study of 6,608 rheumatic disease patients. J Rheumatol 1995;20:2025-31.
10. Decker JL, McShane DJ, Esdaile JM, et al: Dictionary of the Rheumatic Diseases: Vol I: Signs and Symptoms. New York: Contact Associates International, 1982.
11. Stata Corporation: Stata Statistical Software: Release 4.0. College Station, TX: Stata Corporation, 1995.
12. Goldstein R: Testing dependent correlation coefficients. Stata Technical Bulletin 1996;32:
13. Sipe JD: Acute-phase proteins in osteoarthritis. Semin Arthritis Rheum 1995;25:75-86.
14. Shine B, de Beer FC, Pepys MB: Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta 1981;117:13-23.
15. Claus DR, Osmand AP, Gewurz H: Radioimmunoassay of human C-reactive protein and levels in normal sera. J Lab Clin Med 1976;87:120-8.
16. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study [see comments]. BMJ 1996;312:1061-5.
17. Hochberg MC, Lethbridge-Cejku M, Scott WW, Reichle R, Plato CC, Tobin JD: The association of body weight, body fatness and body fat distribution with osteoarthritis of the knee: Data from the Baltimore Longitudinal Study of Aging. J Rheumatol 1995;22:488-93.
18. Philbin EF, Groff GD, Ries MD, Miller TE: Cardiovascular fitness and health in patients with end-stage osteoarthritis. Arthritis Rheum 1995;38:799-805.